Literature DB >> 3287139

Spectrotypic analysis of antibodies to insulin A and B chains.

J W Thomas1, M Beckwith, L J Nell.   

Abstract

Antibodies produced by immunization with native insulin were analyzed by isoelectric focusing for binding to isolated A and B chains. Antibodies to isolated A chain of beef insulin were found to have restricted spectrotypes and were seen after immunization with either beef or human insulin. Hyperimmunization with beef insulin, but not human, increased the heterogeneity of anti-A chain antibodies. Antibodies to isolated B chains were also electrophoretically restricted but showed less heterogeneity after hyperimmunization than anti-A chain responses. When binding to chains was carried out in the presence of excess cold insulin, anti-B chain spectrotypes were inhibited by the native molecule. In contrast, only a portion of anti-A chain spectrotypes were inhibited by native insulin, suggesting that these clonotypes are directed at epitopes not present on the surface of the molecule. These data indicate that the anti-insulin repertoire includes antibodies that can bind isolated chains as well as the native molecule. Some of the determinants on isolated A chain are not available on intact insulin and may arise from antigen catabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3287139     DOI: 10.1016/0161-5890(88)90065-x

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  1 in total

1.  Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes status.

Authors:  Bernice Lo; Austin D E Swafford; Kimberly A Shafer-Weaver; Lawrence F Jerome; Luba Rakhlin; Douglas R Mathern; Conor A Callahan; Ping Jiang; Lucy J Davison; Helen E Stevens; Carrie L Lucas; Jill White; Reid von Borstel; John A Todd; Michael J Lenardo
Journal:  J Transl Med       Date:  2011-11-28       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.